1887
Surveillance Open Access
Like 0

Abstract

Background

In 2012, Israel’s National Center for Infection Control initiated a national stewardship programme that included mandatory annual reporting of antimicrobial use. Here we present nationwide Israeli data for the period 2012 to 2017.

Aim

The goal of this study was to detect trends in antimicrobial use in Israel following the introduction of the stewardship programme, as part of an assessment of the programme’s impact.

Methods

In this retrospective observational study, data were collected from Israel’s health maintenance organisations (HMOs), acute care hospitals and post-acute care hospitals (PACHs). Acute care hospital data were collected for general medical and surgical wards, and medical/surgical intensive care units (ICUs). Data were converted into defined daily doses (DDD), with use rates presented as DDD per 1,000 insured/day in the community and DDD per 100 patient-days in hospitals and PACHs. Trends were analysed using linear regression.

Results

Antimicrobial use decreased across sectors between 2012 and 2017. In the community, the decrease was modest, from 22.8 to 21.8 DDD per 1,000 insured per day (4.4%, p = 0.004). In acute care hospitals, antibiotic DDDs per 100 patient-days decreased from 100.0 to 84.0 (16.0%, p = 0.002) in medical wards, from 112.8 to 94.2 (16.5%, p = 0.004) in surgical wards and from 154.4 to 137.2 (11.1%, p = 0.04) in ICUs. Antimicrobial use decreased most markedly in PACHs, from 29.1 to 18.1 DDD per 100 patient-days (37.8%, p = 0.005).

Conclusion

Between 2012 and 2017, antimicrobial use decreased significantly in all types of healthcare institutions in Israel, following the introduction of the nationwide antimicrobial stewardship programme.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2019.24.34.1900022
2019-08-22
2019-11-12
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2019.24.34.1900022
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/24/34/eurosurv-24-34-4.html?itemId=/content/10.2807/1560-7917.ES.2019.24.34.1900022&mimeType=html&fmt=ahah

References

  1. European Centre for Disease Prevention and Control (ECDC). Antimicrobial consumption. In: ECDC. Annual epidemiological report 2017. Stockholm: ECDC; 2018. Available from: https://ecdc.europa.eu/sites/portal/files/documents/ESAC-NET-reportAER-2017-updated.pdf
  2. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742-50.  https://doi.org/10.1016/S1473-3099(14)70780-7  PMID: 25022435 
  3. Gaygısız Ü, Lajunen T, Gaygısız E. Socio-economic factors, cultural values, national personality and antibiotics use: A cross-cultural study among European countries. J Infect Public Health. 2017;10(6):755-60.  https://doi.org/10.1016/j.jiph.2016.11.011  PMID: 28209467 
  4. European Centre for Disease Prevention and Control (ECDC). Summary of the latest data on antibiotic resistance in the European Union: EARS-Net surveillance data. Stockholm: ECDC; November 2017. Available from: https://ecdc.europa.eu/sites/portal/files/documents/EAAD%20EARS-Net%20summary.pdf
  5. Pan American Health Organization (PAHO). Informe anual de la red de monitoreo/vigilanciade la resistencia a los antibióticos y de infecciones asociadas a la atención de la salud – 2014. [Annual Report of the Network for Monitoring/Surveillance of Antibiotic Resistance and Health Care Associated Infections – 2014]. Goiânia: PAHO; 2014. [Accessed 15 Aug 2019]. Spanish. Available from: https://www.paho.org/hq/dmdocuments/2017/2014-cha-informe-anual-relavra.pdf
  6. World Health Organization (WHO). Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early implementation 2016-2017. Geneva: WHO; 2017. Available from: http://apps.who.int/iris/bitstream/handle/10665/259744/9789241513449-eng.pdf?sequence=1
  7. Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14(1):13.  https://doi.org/10.1186/1471-2334-14-13  PMID: 24405683 
  8. Schechner V, Temkin E, Harbarth S, Carmeli Y, Schwaber MJ. Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev. 2013;26(2):289-307.  https://doi.org/10.1128/CMR.00001-13  PMID: 23554418 
  9. Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-77.  https://doi.org/10.1093/cid/ciw118  PMID: 27080992 
  10. Schuts EC, Hulscher MEJL, Mouton JW, Verduin CM, Stuart JWTC, Overdiek HWPM, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847-56.  https://doi.org/10.1016/S1473-3099(16)00065-7  PMID: 26947617 
  11. Dixon J, Duncan CJ. Importance of antimicrobial stewardship to the English National Health Service. Infect Drug Resist. 2014;7:145-52. PMID: 24936131 
  12. Honda H, Ohmagari N, Tokuda Y, Mattar C, Warren DK. Antimicrobial Stewardship in Inpatient Settings in the Asia Pacific Region: A Systematic Review and Meta-analysis. Clin Infect Dis. 2017;64(suppl_2):S119-26.  https://doi.org/10.1093/cid/cix017  PMID: 28475777 
  13. Low M, Nitzan O, Bitterman H, Cohen C, Hammerman A, Lieberman N, et al. Trends in outpatient antibiotic use in Israel during the years 2000-2010: setting targets for an intervention. Infection. 2013;41(2):401-7.  https://doi.org/10.1007/s15010-012-0332-8  PMID: 23001542 
  14. Bitterman R, Raz-Pasteur A, Azzam ZS, Karban A, Levy Y, Hayek T, et al. [reduction of antibiotic consumption in Rambam health care campus - the role of an antibiotic stewardship program]. Harefuah. 2017;156(9):573-7. PMID: 28971655 
  15. Kitzes-Cohen R, Koos D, Levy M. Patterns of systemic antibiotic use in a tertiary hospital in Israel in the years 1998-2000. Int J Clin Pharmacol Ther. 2004;42(4):246-52.  https://doi.org/10.5414/CPP42246  PMID: 15124983 
  16. Raveh D, Levy Y, Schlesinger Y, Greenberg A, Rudensky B, Yinnon AM. Longitudinal surveillance of antibiotic use in the hospital. QJM. 2001;94(3):141-52.  https://doi.org/10.1093/qjmed/94.3.141  PMID: 11259689 
  17. Shalit I, Low M, Levy E, Chowers M, Zimhony O, Riesenberg K, et al. Antibiotic use in 26 departments of internal medicine in 6 general hospitals in Israel: variability and contributing factors. J Antimicrob Chemother. 2008;62(1):196-204.  https://doi.org/10.1093/jac/dkn150  PMID: 18400806 
  18. Schwaber MJ, Carmeli Y. The Impact of a Carbapenem-Resistant Enterobacteriaceae Outbreak on Facilitating Development of a National Infrastructure for Infection Control in Israel. Clin Infect Dis. 2017;65(12):2144-9.  https://doi.org/10.1093/cid/cix615  PMID: 29020228 
  19. World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2016. [Accessed 13 Nov 2018]. Available from: https://www.whocc.no/atc_ddd_index/.
  20. World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology. ATC alterations from 2005-2019. [Accessed 15 Aug 2019]. Available from: https://www.whocc.no/atc_ddd_alterations__cumulative/atc_alterations/
  21. Temkin E, Fallach N, Almagor J, Gladstone BP, Tacconelli E, Carmeli YDRIVE-AB Consortium. Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study. Lancet Glob Health. 2018;6(9):e969-79.  https://doi.org/10.1016/S2214-109X(18)30278-X  PMID: 30103998 
  22. Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008;8(2):125-32.  https://doi.org/10.1016/S1473-3099(08)70017-3  PMID: 18222163 
  23. Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle PY, et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med. 2009;6(6):e1000084.  https://doi.org/10.1371/journal.pmed.1000084  PMID: 19492093 
  24. Nathwani D, Sneddon J, Malcolm W, Wiuff C, Patton A, Hurding S, et al. Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents. 2011;38(1):16-26.  https://doi.org/10.1016/j.ijantimicag.2011.02.005  PMID: 21515030 
  25. European Centre for Disease Prevention and Control (ECDC). TESSy -The European Surveillance System. Antimicrobial consumption (AMC) reporting protocol 2018. European Surveillance of Antimicrobial Consumption Network (ESAC-Net) surveillance data for 2017. Stockholm: ECDC; July 2018. [Accessed 13 Nov 2018]. Available from: https://ecdc.europa.eu/sites/portal/files/documents/ESAC-Net_Reporting_Protocol_2018_update_July_2018.pdf
  26. Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6(6):e619-29.  https://doi.org/10.1016/S2214-109X(18)30186-4  PMID: 29681513 
/content/10.2807/1560-7917.ES.2019.24.34.1900022
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error